The Weekly Brief

Enjoying this newsletter? Know someone who would too? Forward this email to them!
Sign up (it’s free)

October 17th 2025

💻 Technology

Japanese company Science Co. has introduced the “Human Washer in the Future,” a fully automated bathing system that uses sensors, warm soap water, and calming visuals to deliver hands-free, spa-style showers. Displayed at the 2025 Osaka Expo, the device recycles water, maintains ideal temperatures, and integrates immersive nature sounds for relaxation. Inspired by Japan’s rich bathing culture, it blends hygiene, accessibility, and sustainability into one futuristic design.

🦾 Robotics

Australian company FBR Limited has tested its upgraded Hadrian robot, which can lay up to 360 bricks per hour with high precision using dynamic stabilization and custom software. Mounted on a mobile truck, the system turns digital wall designs into physical structures while reducing material waste and labor needs. The robot could significantly accelerate residential and commercial construction, promising faster builds with fewer workers.

🤖 Artificial Intelligence

Google DeepMind and Yale University have developed C2S-Scale 27B, an advanced AI model that identified a novel way to make “cold” tumors visible to the immune system, potentially boosting cancer immunotherapy. Published findings show the AI predicted that combining the drug silmitasertib with low-dose interferon significantly increased immune recognition in lab-tested tumor cells. This breakthrough could guide future treatments for cancers that typically evade immune detection.

💉 Biotechnology

Researchers at the University of Cambridge have created "hematoids" - 3D embryo-like stem cell structures that mimic natural blood formation and produce multiple blood cell types, including immune cells. Published in Cell Reports, the discovery could enable personalized blood production, model blood disorders like leukemia, and improve stem cell transplant therapies. The system self-directs development, offering a realistic and ethical way to study early human blood formation.

💊 Healthcare

Researchers at Michigan State University have identified a key enzyme, aldolase, that controls how sperm rapidly increase energy production during activation - an essential step for fertilization. Published in Proceedings of the National Academy of Sciences, the study reveals how sperm metabolize glucose and tap internal fuel stores to power their final journey. This discovery could lead to nonhormonal, reversible male contraceptives that work by temporarily blocking sperm activity instead of production.

Researchers at Mass General Brigham have created HPV-DeepSeek, a blood test that identifies HPV-related head and neck cancers up to a decade before symptoms appear by detecting viral DNA fragments in the bloodstream. Published in the Journal of the National Cancer Institute, the test demonstrated 99% sensitivity and specificity, enabling earlier, less invasive treatment and significantly improving survival prospects. A large NIH-backed trial is now underway to validate the results.

That’s all for today, please reply to this email if you have any comments or feedback, we’d love to hear from you about what we can do better!

Have you enjoyed this email? Make sure to share it with your friends and colleagues.

See you soon,

Max

Reply

or to participate

Recommended for you

No posts found